Roberto Bugarini
Arcturus Therapeutics (United States)(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HIV Research and Treatment, HIV/AIDS drug development and treatment, Viral-associated cancers and disorders, Influenza Virus Research Studies
Most-Cited Works
- → Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial(2009)1,391 cited
- → Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study(2010)722 cited
- → HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma(2002)310 cited
- → Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy(2005)283 cited
- → Age‐related disability in multiple sclerosis(2002)182 cited
- → An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine(2006)120 cited
- → Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies(2003)111 cited
- → Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers(2006)103 cited
- → Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAART(2001)93 cited
- → Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture(2009)80 cited